Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Why Avoid Individual Stocks highlights the risks of single-stock bets and why broad index funds offer steadier long-term growth for most investors.
22,058 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A high pre-tax withdrawal can push Social Security into higher taxation, prolonging Medicare costs and altering retir...
A prominent on-chain researcher raised alarms about AscendEX withdrawal processing, with users reporting multi-day de...
A new industry view reframes AI as a productivity boost that reshapes tasks, not a job killer, while Gen Z markets fi...
Bitcoin faces renewed selling from large holders while smaller investors buy the dip. On-chain data reveals a widenin...
Palantir Technologies stock charged higher today after a bullish analyst note highlighted AI momentum and enterprise ...
Retiring to Cape Coral with a $900,000 portfolio and a waterfront home sounds idyllic, but the true cost includes tax...
Medicare surcharges tied to income jump in 2026, placing retirees in the irmaa five income brackets. Crossing the fir...
A retired couple confronts a tax cliff as their home equity climbs. They choose to stay, prioritizing a stepped-up ba...
Meta is pursuing a bold, dual-track strategy: build massive data centers to fuel AI workloads while exploring a poten...
May 2026 data from the Federal Reserve show consumer credit contracted, ending a six-month gain. Analysts warn the pu...
As market conditions evolve in 2026, DGRO’s dividend growth and low costs make a compelling case for holding DGRO in ...